Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients

Publisher： Karger

E-ISSN： 1421-9824|34|3-4|167-173

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.34, Iss.3-4, 2012-10, pp. : 167-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of a Rivastigmine Patch on Self-Care Activities in Patients with Alzheimer's Disease plus Cerebrovascular Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 4, Iss. 3, 2014-10 ,pp. : 395-401

Karger

Access to resources Recommend Favorite

Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 29, Iss. 5, 2010-05 ,pp. : 406-412

Karger

Access to resources Recommend Favorite

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 150-162

Karger

Access to resources Recommend Favorite

Domain-Specific Improvement of Cognition on Memantine in Patients with Alzheimer’s Disease Treated with Rivastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 5, 2007-03 ,pp. : 301-306

Karger

Access to resources Recommend Favorite